|
|
Article: 'Miracle' drugs tempt the terminally ill: protease inhibitors complicate hospice guidelines.
- Article from:
- AIDS Alert
- Article date:
- December 1, 1996
CopyrightCOPYRIGHT 1996 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Terri Ford's friend had been an AIDS activist for years, fighting for faster approval of new and better anti-HIV drugs. Recently, the young man's health failed so rapidly that it was too late for him to take advantage of the much-heralded protease inhibitors.
Now under hospice care, the young man won the battle for improved AIDS treatment but has lost the war.
"If he had just stayed healthy one more year he might be a survivor," says Ford, director of Lynn House, a 25-bed AIDS hospice in Los Angeles. "It's sad. He was so close."
How close is close enough? That is the difficult question many providers and patients are asking in the face of ...